The aim of the present study was to study the effect of parity on the efficacy of Ovsynch protocol in buffalo. Out of 686 buffalo heifers (HE) and 273 cows (BC), 8 heifers and 9 cows were used to monitor and evaluate ovarian follicular dynamics and serum progesterone profile during this protocol while the rest of animals were used to compare the conception rate following the application of this...

Few successful pregnancies after age 45 years with low ovarian reserve have been reported. We report a 46-year-old woman with basal FSH 20.36 mIU/mL and an antral follicle count of four obtained two embryos and delivered a healthy infant with IVF using a microdose GnRH-a flare-up protocol combined with GnRH-ant.

Purified human menopausal gonadotropin (HMG) is a natural product extracted from the urine of postmenopausal women that contains pituitary follicle-stimulating hormone (FSH), luteinizing hormone (LH), and a small amount of human chorionic gonadotropin (HCG). Here we retrospectively conducted a clinical pharmaceutical study on a cohort of normogonadotropic infertile patients addressed to long Gn...

BACKGROUND We aimed to compare human menopausal gonadotropin (hMG) and recombinant follicle-stimulating hormone (r FSH) with respect to clinical outcomes and the development of ovarian hyperstimulation syndrome (OHSS) for patients with polycystic ovary syndrome (PCOS) treated with in vitro fertilization (IVF). MATERIALS AND METHODS This prospective randomized controlled trial included a total...

BACKGROUND Highly purified hMG (hp-hMG) has recently shown better cycle outcome than the recombinant FSH (rFSH) when compared in GnRH agonist long protocol cycles. However, they have not yet been compared in GnRH antagonist cycles. METHODS A RCT comparing the ongoing pregnancy rate (primary end-point) in 280 patients undergoing IVF/ICSI after stimulation with hp-hMG or rFSH controlled with a ...

The aim of this study was to investigate the relationships among the ages of patients, serum progesterone (P) levels on the day of human chorionic gonadotropin administration (DHCG), and clinical pregnancy rates in a gonadotropin-releasing hormone (GnRH)-agonist long protocol. A total of 5,566 patients followed at the reproductive medicine center of a tertiary care public hospital who were unde...

In order to evaluate whether the ratio of serum estrogen level on the day of human chorionic gonadotrophin (hCG) administration to number of oocyte retrieved has any impact on live birth rate in women undergoing in vitro fertilization (IVF), we retrospectively analyzed the clinical data from 7,112 women treated with GnRH-a long protocol in our center. Cycles were firstly divided into 6 groups a...

The study was undertaken to compare the efficacy of an estradiol-17β + CIDR based protocol with the conventional ovsynch + CIDR based protocol for synchrony of wave emergence and ovulation in Murrah buffalos. In group I (n=25), on day 0 (beginning of experiment), buffaloes were administered a CIDR device (1.38 g P4) and concurrently received 1.5 mg E-17β. On day 9, the CIDR was removed and a pr...

background: gonadotrophin-releasing hormone (gnrh) agonist is used for controlling ovarian stimulation in assisted reproductive technology (art) cycles which has some benefits. objective: to compare the efficacy of two different formulations of gnrh agonist: short-acting and long-acting, for art protocols. materials and methods: in a prospective randomized study, one hundred women who underwent...

We believe that appropriate comparison of optimal GnRH agonist and antagonist regimens has not been performed yet. Currently available meta-analyses included all comparative studies between GnRH agonists and antagonists performed so far, including less than optimal GnRH antagonist regimens. After critical appraisal of the various studied GnRH antagonist regimens in terms of follicular developme...